Kedrion Biopharma is a leading international biopharmaceutical company that specializes in the development, production, and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders, and conditions such as immune system deficiencies and coagulation disorders. Kedrion has special expertise in the treatment of rare diseases and the manufacture of hyper-immune products such as anti-hepatitis B, anti-tetanus, and RhoGAM® for prophylaxis against Rh sensitization and subsequent hemolytic disease of the fetus and newborn.